Hikma Pharmaceuticals PLC (HIK)

Industry Drug Manufacturers - Specialty & Generic

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

1,495.00p

Buy

1,497.00p

arrow-down-7.00p (-0.47%)

Prices updated at 16 Dec 2025, 15:12 GMT

Prices minimum 15 mins delay

Prices in GBX

Hikma Pharmaceuticals PLC develops, manufactures and markets a broad range of branded and non-branded generic pharmaceutical products across the US, the MENA region, and Europe.

FTSE All-Share

-0.71%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2023	2024
	2,875m	3,127m
	1,390m	1,415m
	610m	612m
	21.22	19.57
	190m	359m
	552m	727m
Sales, General and administrative	544m	568m
Interest expenses	73m	75m
Provision for income taxes	89m	93m
Operating expenses	780m	803m
Income before taxes	281m	455m
Net income available to common shareholders	190m	359m
	0.86	1.62
Net interest income	-80m	-80m
Advertising and promotion	-	-
Net investment income, net	-9m	-21m
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	0.85	1.61
Free cash flow per share	1.309	1.8136
Book value/share	7.7767	8.2648
Debt equity ratio	0.468608	0.282684

Balance sheet

Year chevron-l-regular chevron-r-regular	2023	2024
Current assets	2,100m	2,263m
Current liabilities	1,339m	1,978m
Total capital	3,173m	2,917m
Total debt	1,191m	1,306m
Total equity	2,198m	2,310m
Total non current liabilities	-	-
Loans	975m	607m
Total assets	4,680m	5,133m
Total liabilities	-	-
Cash and cash equivalents	205m	188m
Common stock	221m	220m

Cash flow

Year chevron-l-regular chevron-r-regular	2023	2024
Cash at beginning of period	270m	205m
Cash dividends paid	-137m	-175m
	533m	329m
Investments (gains) losses	-333m	-381m
	205m	188m
Net income	-	-
	737m	564m
	-204m	-235m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.